1. CMPS will participate in multiple September investor conferences. 2. Management's engagement may increase visibility and investor interest. 3. COMP360 has Breakthrough Therapy designation from the FDA. 4. Innovative model for mental health treatment is under development.
Ongoing conferences can boost investor interest, improving demand for CMPS shares. Previous participation in investor conferences has led to positive market reactions.
Conferences enhance CMPS's exposure and can stimulate stock price upswings; hence, significant investment potential.
Events occurring soon could yield immediate investor activity and interest in CMPS. Past similar situations show an uptick in trading volumes and stock prices shortly after such events.
Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the following September investor conferences:
A live audio webcast of these events will be accessible from the "Events" page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event.
About Compass Pathways
Compass Pathways plc (NASDAQ:CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are living with mental health challenges and who are not helped by existing standards of care. We are pioneering the development of a new model of psilocybin treatment, in which our proprietary formulation of synthesized psilocybin, COMP360, is administered in conjunction with psychological support. COMP360 has Breakthrough Therapy designation from the US Food and Drug Administration (FDA) and has received Innovative Licensing and Access Pathway (ILAP) designation in the UK for treatment-resistant depression (TRD).
Compass is headquartered in London, UK, with offices in New York in the U.S. We envision a world where mental health means not just the absence of illness but the ability to thrive.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250827807367/en/
Enquiries
Media: Dana Sultan-Rothman, media@compasspathways.com, +1 484 432 0041
Investors: Stephen Schultz, stephen.schultz@compasspathways.com, +1 401 290 7324